Aelis Farma
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Qualitative Effects of AEF0217 in Down Syndrome People (NCT07413224) | Aelis Farma | 2026-03-01 |
| The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers (NCT05451017) | Aelis Farma | 2023-01-04 |
| Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects (NCT05554926) | Aelis Farma | 2022-12-16 |
| Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome (NCT05748405) | Aelis Farma | 2022-12-15 |
| Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) (NCT05322941) | Aelis Farma | 2022-05-06 |
| AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects. (NCT05170737) | Aelis Farma | 2021-10-01 |
| Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects (NCT03717272) | Aelis Farma | 2018-10-23 |
| Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117 (NCT03443895) | Aelis Farma | 2018-01-08 |
Track Aelis Farma automatically
Every clearance here is in the API, with alerts when new ones post.